254 related articles for article (PubMed ID: 25524703)
1. Targeting the effector domain of the myristoylated alanine rich C-kinase substrate enhances lung cancer radiation sensitivity.
Rohrbach TD; Jarboe JS; Anderson JC; Trummell HQ; Hicks PH; Weaver AN; Yang ES; Oster RA; Deshane JS; Steele C; Siegal GP; Bonner JA; Willey CD
Int J Oncol; 2015 Mar; 46(3):1079-88. PubMed ID: 25524703
[TBL] [Abstract][Full Text] [Related]
2. Targeting myristoylated alanine-rich C kinase substrate phosphorylation site domain in lung cancer. Mechanisms and therapeutic implications.
Chen CH; Statt S; Chiu CL; Thai P; Arif M; Adler KB; Wu R
Am J Respir Crit Care Med; 2014 Nov; 190(10):1127-38. PubMed ID: 25318062
[TBL] [Abstract][Full Text] [Related]
3. A peptide that inhibits function of Myristoylated Alanine-Rich C Kinase Substrate (MARCKS) reduces lung cancer metastasis.
Chen CH; Thai P; Yoneda K; Adler KB; Yang PC; Wu R
Oncogene; 2014 Jul; 33(28):3696-706. PubMed ID: 23955080
[TBL] [Abstract][Full Text] [Related]
4. MARCKS phosphorylation is modulated by a peptide mimetic of MARCKS effector domain leading to increased radiation sensitivity in lung cancer cell lines.
Rohrbach TD; Jones RB; Hicks PH; Weaver AN; Cooper TS; Eustace NJ; Yang ES; Jarboe JS; Anderson JC; Willey CD
Oncol Lett; 2017 Mar; 13(3):1216-1222. PubMed ID: 28454237
[TBL] [Abstract][Full Text] [Related]
5. Myristoylated alanine-rich C-kinase substrate effector domain phosphorylation regulates the growth and radiation sensitization of glioblastoma.
Eustace NJ; Anderson JC; Langford CP; Trummell HQ; Hicks PH; Jarboe JS; Mobley JA; Hjelmeland AB; Hackney JR; Pedersen RT; Cosby K; Gillespie GY; Bonner JA; Willey CD
Int J Oncol; 2019 Jun; 54(6):2039-2053. PubMed ID: 30942445
[TBL] [Abstract][Full Text] [Related]
6. Regulation of PI3K by PKC and MARCKS: Single-Molecule Analysis of a Reconstituted Signaling Pathway.
Ziemba BP; Burke JE; Masson G; Williams RL; Falke JJ
Biophys J; 2016 Apr; 110(8):1811-1825. PubMed ID: 27119641
[TBL] [Abstract][Full Text] [Related]
7. Functional involvement of protein kinase C-betaII and its substrate, myristoylated alanine-rich C-kinase substrate (MARCKS), in insulin-stimulated glucose transport in L6 rat skeletal muscle cells.
Chappell DS; Patel NA; Jiang K; Li P; Watson JE; Byers DM; Cooper DR
Diabetologia; 2009 May; 52(5):901-11. PubMed ID: 19252893
[TBL] [Abstract][Full Text] [Related]
8. The Effector Domain of MARCKS Is a Nuclear Localization Signal that Regulates Cellular PIP2 Levels and Nuclear PIP2 Localization.
Rohrbach TD; Shah N; Jackson WP; Feeney EV; Scanlon S; Gish R; Khodadadi R; Hyde SO; Hicks PH; Anderson JC; Jarboe JS; Willey CD
PLoS One; 2015; 10(10):e0140870. PubMed ID: 26470026
[TBL] [Abstract][Full Text] [Related]
9. Functional characterization of the tumor-suppressor MARCKS in colorectal cancer and its association with survival.
Bickeböller M; Tagscherer KE; Kloor M; Jansen L; Chang-Claude J; Brenner H; Hoffmeister M; Toth C; Schirmacher P; Roth W; Bläker H
Oncogene; 2015 Feb; 34(9):1150-9. PubMed ID: 24662837
[TBL] [Abstract][Full Text] [Related]
10. Regulation of a Coupled MARCKS-PI3K Lipid Kinase Circuit by Calmodulin: Single-Molecule Analysis of a Membrane-Bound Signaling Module.
Ziemba BP; Swisher GH; Masson G; Burke JE; Williams RL; Falke JJ
Biochemistry; 2016 Nov; 55(46):6395-6405. PubMed ID: 27933776
[TBL] [Abstract][Full Text] [Related]
11. Upregulation of MARCKS in kidney cancer and its potential as a therapeutic target.
Chen CH; Fong LWR; Yu E; Wu R; Trott JF; Weiss RH
Oncogene; 2017 Jun; 36(25):3588-3598. PubMed ID: 28166200
[TBL] [Abstract][Full Text] [Related]
12. Binding of myristoylated alanine-rich protein kinase C substrate to phosphoinositides attenuates the phosphorylation by protein kinase C.
Seki K; Sheu FS; Huang KP
Arch Biochem Biophys; 1996 Feb; 326(2):193-201. PubMed ID: 8611023
[TBL] [Abstract][Full Text] [Related]
13. Protein kinase C-mediated phosphorylation of the myristoylated alanine-rich C-kinase substrate protects it from specific proteolytic cleavage.
Spizz G; Blackshear PJ
J Biol Chem; 1996 Jan; 271(1):553-62. PubMed ID: 8550618
[TBL] [Abstract][Full Text] [Related]
14. Sequestration of phosphoinositides by mutated MARCKS effector domain inhibits stimulated Ca(2+) mobilization and degranulation in mast cells.
Gadi D; Wagenknecht-Wiesner A; Holowka D; Baird B
Mol Biol Cell; 2011 Dec; 22(24):4908-17. PubMed ID: 22013076
[TBL] [Abstract][Full Text] [Related]
15. Fibroblast Migration Is Regulated by Myristoylated Alanine-Rich C-Kinase Substrate (MARCKS) Protein.
Ott LE; Sung EJ; Melvin AT; Sheats MK; Haugh JM; Adler KB; Jones SL
PLoS One; 2013; 8(6):e66512. PubMed ID: 23840497
[TBL] [Abstract][Full Text] [Related]
16. Prognostic Value of Upregulation of Myristoylated Alanine-Rich C-Kinase Substrate in Gastric Cancer.
Quan R; Ning Z; Wang Y; Yu W; Zhu H
Med Sci Monit; 2019 Jan; 25():279-287. PubMed ID: 30623893
[TBL] [Abstract][Full Text] [Related]
17. Phosphorylation of myristoylated alanine-rich C kinase substrate is involved in the cAMP-dependent amylase release in parotid acinar cells.
Satoh K; Matsuki-Fukushima M; Qi B; Guo MY; Narita T; Fujita-Yoshigaki J; Sugiya H
Am J Physiol Gastrointest Liver Physiol; 2009 Jun; 296(6):G1382-90. PubMed ID: 19372103
[TBL] [Abstract][Full Text] [Related]
18. A novel predictor of cancer malignancy: up-regulation of myristoylated alanine-rich C kinase substrate phosphorylation in lung cancer.
Chen CH; Chiu CL; Adler KB; Wu R
Am J Respir Crit Care Med; 2014 Apr; 189(8):1002-4. PubMed ID: 24735036
[No Abstract] [Full Text] [Related]
19. Myristoylated alanine-rich C kinase substrate phosphorylation promotes cholangiocarcinoma cell migration and metastasis via the protein kinase C-dependent pathway.
Techasen A; Loilome W; Namwat N; Takahashi E; Sugihara E; Puapairoj A; Miwa M; Saya H; Yongvanit P
Cancer Sci; 2010 Mar; 101(3):658-65. PubMed ID: 20047593
[TBL] [Abstract][Full Text] [Related]
20. MARCKS protein is phosphorylated and regulates calcium mobilization during human acrosomal exocytosis.
Rodriguez Peña MJ; Castillo Bennett JV; Soler OM; Mayorga LS; Michaut MA
PLoS One; 2013; 8(5):e64551. PubMed ID: 23704996
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
